{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:33:17Z","timestamp":1787063597139,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008982","name":"NSF","doi-asserted-by":"publisher","award":["CHE-1429195"],"award-info":[{"award-number":["CHE-1429195"]}],"id":[{"id":"10.13039\/501100008982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006630","name":"Utah State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006630","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ejmech.2018.08.018","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T12:47:20Z","timestamp":1533559640000},"page":"683-690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Tuning the biological activity of cationic anthraquinone analogues specifically toward Staphylococcus aureus"],"prefix":"10.1016","volume":"157","author":[{"given":"Yagya Prasad","family":"Subedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madher N.","family":"Alfindee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya P.","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8978-4520","authenticated-orcid":false,"given":"Cheng-Wei Tom","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.08.018_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.14737\/journal.aavs\/2015\/3.2.79.98","article-title":"Methicillin resistant Staphyloccus aureus (MRSA): a review","volume":"3","author":"Grema","year":"2015","journal-title":"Adv. Anim. Vet. Sci."},{"key":"10.1016\/j.ejmech.2018.08.018_bib2","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1093\/cid\/cit614","article-title":"Methicillin-resistant Staphylococcus aureus therapy: past, present, and future","volume":"58","author":"Rodvold","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.08.018_bib3","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/cid\/cit613","article-title":"Methicillin-resistant Staphylococcus aureus: an evolving pathogen","volume":"58","author":"Stryjewski","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.08.018_bib4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.qco.0000171923.62699.0c","article-title":"Vancomycin-resistant staphylococci and enterococci: epidemiology and control","volume":"18","author":"Tenover","year":"2005","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.08.018_bib5","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/aje\/kws273","article-title":"The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: a national observational study","volume":"177","author":"Klein","year":"2013","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ejmech.2018.08.018_bib6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1017\/S0950268814001423","article-title":"Epidemiological survey of the first case of vancomycin-resistant Staphylococcus aureus infection in Europe","volume":"143","author":"Fri\u00e3es","year":"2015","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.ejmech.2018.08.018_bib7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3201\/eid1506.081312","article-title":"Vancomycin-resistant Staphylococcus aureus, Michigan, USA, 2007","volume":"15","author":"Finks","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.08.018_bib8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/jac\/46.4.523","article-title":"Development of daptomycin for gram-positive infections","volume":"46","author":"Tally","year":"2000","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2018.08.018_bib9","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1128\/JCM.43.10.5285-5287.2005","article-title":"Development of daptomycin resistance in\u00a0vivo in methicillin-resistant Staphylococcus aureus","volume":"43","author":"Hayden","year":"2005","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.ejmech.2018.08.018_bib10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","article-title":"Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus","volume":"50","author":"Cui","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.018_bib11","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1128\/JCM.00179-07","article-title":"Detection of mutations conferring resistance to linezolid in Enterococcus spp. by fluorescence in situ hybridization","volume":"45","author":"Werner","year":"2007","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.ejmech.2018.08.018_bib12","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1128\/JCM.00165-06","article-title":"Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus","volume":"44","author":"Asha","year":"2006","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.ejmech.2018.08.018_bib13","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1128\/AAC.00019-06","article-title":"Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid","volume":"50","author":"Nor\u00e9n","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.018_bib14","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMra1403772","article-title":"Clostridium difficile infection","volume":"372","author":"Leffler","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2018.08.018_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1021\/co2002075","article-title":"Library synthesis and antibacterial investigation of cationic anthraquinone analogs","volume":"14","author":"Fosso","year":"2012","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.ejmech.2018.08.018_bib16","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ejmech.2016.12.008","article-title":"Synthesis and bioactivity investigation of quinone-based dimeric cationic triazolium amphiphiles selective against resistant fungal and bacterial pathogens","volume":"126","author":"Shrestha","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.018_bib17","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bmc.2010.11.001","article-title":"Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs","volume":"19","author":"Zhang","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.018_bib18","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1016\/j.bmcl.2011.08.107","article-title":"Mode of action investigation for the antibacterial cationic anthraquinone analogs","volume":"21","author":"Chan","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.018_bib19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejmech.2014.02.060","article-title":"Synthesis and anticancer structure activity relationship investigation of cationic anthraquinone analogs","volume":"77","author":"Shrestha","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.018_bib20","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1016\/j.bmcl.2013.08.078","article-title":"Safe and easy route for the synthesis of 1, 3-dimethyl-1, 2, 3-triazolium salt and investigation of its anticancer activities","volume":"23","author":"Shrestha","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.018_bib21","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1039\/C5MD00314H","article-title":"A\u00a0mode of action study of cationic anthraquinone analogs: a new class of highly potent anticancer agents","volume":"6","author":"Shrestha","year":"2015","journal-title":"Med. Chem. Comm."},{"key":"10.1016\/j.ejmech.2018.08.018_bib22","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/14786419.2010.551297","article-title":"Comparison of antimicrobial activities of naphthoquinones from Impatiens balsamina","volume":"26","author":"Sakunphueak","year":"2012","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2018.08.018_bib23","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1021\/np8001833","article-title":"Isolation, structure, and antibacterial activity of phaeosphenone from a Phaeosphaeria sp. discovered by antisense strategy","volume":"71","author":"Zhang","year":"2008","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2018.08.018_bib24","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1007\/s00044-016-1550-x","article-title":"Synthesis, antibacterial and antifungal activities of naphthoquinone derivatives: a structure\u2013activity relationship study","volume":"25","author":"S\u00e1nchez-Calvo","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.08.018_bib25","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1021\/np010599w","article-title":"Antimicrobial activities of naphthazarins from arnebia e uchroma","volume":"65","author":"Shen","year":"2002","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2018.08.018_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mib.2014.06.008","article-title":"Reactive oxygen species and the bacterial response to lethal stress","volume":"21","author":"Zhao","year":"2014","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2018.08.018_bib27","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1021\/jm800997s","article-title":"Surprising alteration of antibacterial activity of 5\u2032\u2032-modified neomycin against resistant bacteria","volume":"51","author":"Zhang","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.018_bib28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bmc.2017.12.038","article-title":"One-step synthesis of carbohydrate Esters as antibacterial and antifungal agents","volume":"26","author":"AlFindee","year":"2018","journal-title":"Bioorg. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418306767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418306767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:53:04Z","timestamp":1759326784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418306767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":28,"alternative-id":["S0223523418306767"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.08.018","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuning the biological activity of cationic anthraquinone analogues specifically toward Staphylococcus aureus","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}